Hide

MeetDr. Youm

Director of Hip Arthroscopy, NYUBoard-Certified Orthopaedic Surgeon
- Board-Certified Orthopaedic Surgeon with interests in treating athletic injuries
- Specializes in Arthroscopic and Reconstructive Surgery of the shoulder, hip and knee.
- Special interests include joint preservation surgery for the active patient
- Performs cutting edge procedures such as arthroscopic hip labral reconstruction, open femoral and tibial osteotomies for joint preservation, arthroscopic-assisted core decompression for AVN, shoulder reconstruction for instability, and same day total knee and total shoulder replacements.
View Full Profile
Advanced Technologiesfor Your Joint Health
Don't Let Your Joint PainDefine You

FDA approves Eliquis® (apixaban) to reduce the risk of blood clots following hip or knee replacement surgery

Posted on: 08 June, 2017

Bristol-Myers Squibb Company and Pfizer Inc. has announced that the U.S. Food and Drug Administration (FDA) approved a Supplemental New Drug Application (sNDA) for Eliquis (apixaban) for the prophylaxis of deep vein thrombosis (DVT), which may lead to pulmonary embolism (PE), in patients who have undergone hip or knee replacement surgery.